Supreme Rx: 340B Pricing, Baycol Class Action To Get High Court Review
This article was originally published in The Pink Sheet Daily
Executive Summary
The court will consider whether health care providers have the right to file suit to get drug manufacturers to enforce statutory requirements on drug pricing.
You may also be interested in...
Supreme Court Is Wary Of Healthcare Provider Suits Alleging Overpricing By Pharma
During oral arguments in Astra v. Santa Clara County, justices seemed to back pharma's position that 340B entities do not have the right to sue drug makers for violating price ceilings in government contracts.
Supreme Court Is Wary Of Healthcare Provider Suits Alleging Overpricing By Pharma
During oral arguments in Astra v. Santa Clara County, justices seemed to back pharma's position that 340B entities do not have the right to sue drug makers for violating price ceilings in government contracts.
Class Action Law: Is Certification Denial The End Of The Road For Absent Plaintiffs?
Supreme Court asks whether state courts can relitigate federal multidistrict decisions in a class-action case and whether plaintiffs' rights to a day in court are protected.